Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis

Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis

Source: 
CP Wire
snippet: 
  • Changes in familial amyloid polyneuropathy and polyneuropathy disability were significant
  • Earlier indirect comparison of patisiran vs rival indicated patisiran superiority